Featured News
Traverse Biosciences Executes Exclusive, Worldwide License Agreement
Mar 16 2015
NEW YORK, NY
Traverse Biosciences, founded by Joseph Scaduto - one of the Center for Biotechnology's first BioEntrepreneurs-in-Residence, annou
Learn MoreMillennial Materials and Devices Presenting at NY Business Plan Competition FinalsApr 8 2015
Gaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program
Learn MoreNew Mathematical Model May Improve Drug Discovery - Study Co-Authored by CFB's Dr. Eleanor AllenApr 22 2015
A new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug
Learn More-
CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II GrantJuly 30, 2024
This substantial funding from NSF enables IAMBIC to scale its operations.
Learn More -
CFB Client Envisagenics Secures $25 Million Series B Funding to Advance RNA Splicing TherapeuticsJune 10, 2024
Envisagenics, an AI-enabled biotechnology firm specializing in RNA splicing therapeutics, has announced the completion of its Series B funding round. This round included investments from existing supporters Third Kind Venture Capital, Empire State Development, and Red Cell Partners, as well …
Learn More -
In Memory of Dr. James SimonMay 13, 2024
The Center for Biotechnology team would like to express our deepest condolences to the Simons Family on the recent passing of Jim Simons. His impact on both the Stony Brook University community, and around the world was immense, and this …
Learn More
Upcoming Events
24
Mar
Immuno-Oncology 360° Summit
The Center for Biotechnology is a proud supporter of the 11th Annual Immuno-Oncology 360° Summit. This year's event will highlight the latest advancements and data [...]